Masahiro Miyake, Ayako Takahashi, Takayuki Baba, Ichiro Maruko, Masayuki Ohnaka, Akiko Kuroda, Harue Tada, Yu Hidaka, Yumiko Ibi, Yuki Muraoka, et al. Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trial. BMJ Open. 2026. 16. 4. e111780-e111780
Tatsuya Ito, Mika Suzuki, Keiko Sato, Sayaka Takenouchi, Satoshi Kodama, Tetsuji Iseda. Research Culture and Integrity in Japan: A Qualitative Study. Science and Engineering Ethics. 2026
Kambe N., Yamamoto M., Takemura K., Kagami S., Kawahara Y., Yoshifuji H., Jo T., Izawa K., Nakamizo S., Inoue N., et al. Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome. Allergology International. 2024
Hidehiro Someko, Norio Yamamoto, Tatsuya Ito, Tomoharu Suzuki, Takahiro Tsuge, Hajime Yabuzaki, Eisuke Dohi, Yuki Kataoka. Misleading presentations in functional food trials led by contract research organizations were frequently observed in Japan: meta-epidemiological study. Journal of Clinical Epidemiology. 2024. 169. 111302-111302
Hiroki Yamanaka, Eiichi Sawaragi, Takashi Nakano, Yasuhiro Katayama, Tatsuya Ito, Harue Tada, Yu Hidaka, Satoshi Morita, Chihiro Funakoshi, Akemi Kinoshita, et al. A high-hydrostatic pressure device for nevus tissue inactivation and dermal regeneration for reconstructing skin defects after giant congenital melanocytic nevus excision: a clinical trial. Regenerative Therapy. 2023. 24. 167-173
Differences of characteristics in investigator-initiated trials between Japan and other countries. 28th DIA Annual EuroMeeting. 2016
伊藤 達也. Comparison of the research governance frameworks for research involving humans, their tissue and/or data in the UK and Japan. 27th DIA Annual EuroMeeting. 2015
N. Morimoto, K. Yoshimura, M. Niimi, T. Ito, R. Aya, J. Fujitaka, H. Tada, S. Teramukai, T. Murayama, C. Toyooka, et al. Tissue Engineering (vol 19, pg 1931, 2013). TISSUE ENGINEERING PART A. 2014. 20. 13-14. 2030-2030
